Sophia Genetics announced a collaboration with Exactis Innovation, based in Montreal, Quebec, who will contribute to cancer research and data-driven decision-making through Sophia’s multimodal real-world data offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SOPH:
- Sophia Genetics’ Sophia DDM Platform adopted by Paris’ Hopital Saint-Louis
- SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
- Sophia Genetics expands work with CHU de Nimes
- Sophia Genetics initiated with an Outperform at RBC Capital
- Sophia Genetics expands relationship with largest health center in Italy
